Abstract
ABC are anatomically distinct and genetically heterogeneous tumours, characterized by poor response to treatments and overall survival (OS) <12 months. However, an outlier subset of ABC patients (pts) experiencing long-term survival has been identified by an updated analysis of the ABC-02 trial. We aimed at characterizing pattern of care and clinicopathologic features of this population in a real-world setting.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
